The comparison of HSPB2 and HSPB3 mRNA levels between pooled bladder tumors and their matched normal adjacent counterparts revealed a prominent downregulation of the expression of these molecular chaperones in the vast majority of the tumors (Figure 2) indicating a generalized suppression during cancer initiation and progression. The gene discussed is HSPB3; the disease is urinary bladder neoplasm.